Protein kinase networks that limit TLR signalling

Biochemical Society Transactions

Volumn 42, Issue 1, 2014, Pages 11-24

  Clark, Kristopher ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Inhibitor of nuclear factor B kinase (IKK); Innate immunity; Mitogen activated protein kinase (MAPK); Phosphoinositide 3 kinase (PI3K); Salt inducible kinase (SIK); Toll like receptor (TLR)

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 1; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOTRANSFERASE; PROTEIN KINASE; PROTEIN KINASE B; SALT INDUCIBLE KINASE; STRESS ACTIVATED PROTEIN KINASE; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR ASSOCIATED NUCLEAR FACTOR KAPPA B ACTIVATOR PROTEIN; TUMOR PROGRESSION LOCUS 2; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME REPRESSION; HUMAN; INNATE IMMUNITY; LIPOGENESIS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; FEEDBACK, PHYSIOLOGICAL; HUMANS; IMMUNITY, INNATE; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84893327418     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130124     Document Type: Article

References (99)

1. O'Neill, L.A., Golenbock, D. and Bowie, A.G. (2013) The history of Toll-like receptors: redefining innate immunity. Nat. Rev. Immunol. 13, 453-460
2. Guo, Y., Audry, M., Ciancanelli, M., Alsina, L., Azevedo, J., Herman, M., Anguiano, E., Sancho-Shimizu, V., Lorenzo, L., Pauwels, E. et al. (2011) Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208, 2083-2098
3. Santegoets, K.C., van Bon, L., van den Berg, W.B., Wenink, M.H. and Radstake, T.R. (2011) Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? FEBS Lett. 585, 3660-3666
4. Yanai, H., Ban, T. and Taniguchi, T. (2012) High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol. 33, 633-640
5. Nanda, S.K., Venigalla, R.K., Ordureau, A., Patterson-Kane, J.C., Powell, D.W., Toth, R., Arthur, J.S. and Cohen, P. (2011) Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J. Exp. Med. 208, 1215-1228
6. Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T. and Akira, S. (2009) TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 10, 965-972
7. Vereecke, L., Beyaert, R. and van Loo, G. (2009) The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30, 383-391
8. Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., Xu, J.H., Cai, Z.M., Huang, W., Zhao, G.P. et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41, 1234-1237
9. Kawai, T. and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384
10. Enesa, K., Ordureau, A., Smith, H., Barford, D., Cheung, P.C., Patterson-Kane, J., Arthur, J.S. and Cohen, P. (2012) Pellino1 is required for interferon production by viral double-stranded RNA. J. Biol. Chem. 287, 34825-34835
11. Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E., Golenbock, D.T., Coyle, A.J., Liao, S.M. and Maniatis, T. (2003) IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496
12. Smith, H., Liu, X.Y., Dai, L., Goh, E.T., Chan, A.T., Xi, J., Seh, C.C., Qureshi, I.A., Lescar, J., Ruedl, C. et al. (2011) The role of TBK1 and IKKε in the expression and activation of Pellino 1. Biochem. J. 434, 537-548
13. Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O. and Akira, S. (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095
14. Shim, J.H., Xiao, C., Paschal, A.E., Bailey, S.T., Rao, P., Hayden, M.S., Lee, K.Y., Bussey, C., Steckel, M., Tanaka, N. et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681
15. Ajibade, A.A., Wang, Q., Cui, J., Zou, J., Xia, X., Wang, M., Tong, Y., Hui, W., Liu, D., Su, B. et al. (2012) TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+ CD11b+ neutrophils. Immunity 36, 43-54
16. Eftychi, C., Karagianni, N., Alexiou, M., Apostolaki, M. and Kollias, G. (2012) Myeloid TAKI acts as a negative regulator of the LPS response and mediates resistance to endotoxemia. PLoS ONE 7, e31550
17. Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.G. and Su, B. (2004) Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5, 98-103
18. Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K. and Ichijo, H. (2005) ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6, 587-592
19. Wang, C., Deng, L., Hong, M., Akkaraju, G.R., Inoue, J. and Chen, Z.J. (2001) TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351
20. Beinke, S., Deka, J., Lang, V., Belich, M.P., Walker, P.A., Howell, S., Smerdon, S.J., Gamblin, S.J. and Ley, S.C. (2003) NF-κB1 p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23, 4739-4752
21. Waterfield, M.R., Zhang, M., Norman, L.P. and Sun, S.C. (2003) NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Mol. Cell 11, 685-694
22. Lang, V., Janzen, J., Fischer, G.Z., Soneji, Y., Beinke, S., Salmeron, A., Allen, H., Hay, R.T., Ben-Neriah, Y. and Ley, S.C. (2003) βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23, 402-413
23. Yang, H.T., Papoutsopoulou, S., Belich, M., Brender, C., Janzen, J., Gantke, T., Handley, M. and Ley, S.C. (2012) Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-κB1 p105. Mol. Cell. Biol. 32, 3438-3451
24. Dumitru, C.D., Ceci, J.D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.H., Patriotis, C., Jenkins, N.A., Copeland, N.G., Kollias, G. and Tsichlis, P.N. (2000) TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083
25. Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J.M., Prescott, A.R., O'Garra, A., Ley, S.C. and Cohen, P. (2008) TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages. J. Cell Sci. 121, 149-154
26. Kaiser, F., Cook, D., Papoutsopoulou, S., Rajsbaum, R., Wu, X., Yang, H.T., Grant, S., Ricciardi-Castagnoli, P., Tsichlis, P.N., Ley, S.C. and O'Garra, A. (2009) TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206, 1863-1871
27. Boonstra, A., Rajsbaum, R., Holman, M., Marques, R., Asselin-Paturel, C., Pereira, J.P., Bates, E.E., Akira, S., Vieira, P., Liu, Y.J. et al. (2006) Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 177, 7551-7558
28. Deak, M., Clifton, A.D., Lucocq, L.M. and Alessi, D.R. (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17, 4426-4441
29. Ananieva, O., Darragh, J., Johansen, C., Carr, J.M., McIlrath, J., Park, J.M., Wingate, A., Monk, C.E., Toth, R., Santos, S.G. et al. (2008) The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9, 1028-1036
30. Wen, A.Y., Sakamoto, K.M. and Miller, L.S. (2010) The role of the transcription factor CREB in immune function. J. Immunol. 185, 6413-6419
31. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. and O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822
32. Abraham, S.M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J. and Clark, A.R. (2006) Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp. Med. 203, 1883-1889
33. Cheung, P.C., Campbell, D.G., Nebreda, A.R. and Cohen, P. (2003) Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 22, 5793-5805
34. Mendoza, H., Campbell, D.G., Burness, K., Hastie, J., Ronkina, N., Shim, J.H., Arthur, J.S., Davis, R.J., Gaestel, M., Johnson, G.L. et al. (2008) Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem. J. 409, 711-722
35. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. and Bilanges, B. (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341
36. Foster, J.G., Blunt, M.D., Carter, E. and Ward, S.G. (2012) Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies. Pharmacol. Rev. 64, 1027-1054
37. Aksoy, E., Taboubi, S., Torres, D., Delbauve, S., Hachani, A., Whitehead, M.A., Pearce, W.P., Berenjeno-Martin, I., Nock, G., Filloux, A. et al. (2012) The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat. Immunol. 13, 1045-1054
38. Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T. and Koyasu, S. (2002) PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3, 875-881
39. Liu, B.A., Jablonowski, K., Raina, M., Arce, M., Pawson, T. and Nash, P.D. (2006) The human and mouse complement of SH2 domain proteins: establishing the boundaries of phosphotyrosine signaling. Mol. Cell 22, 851-868
40. Sarkar, S.N., Peters, K.L., Elco, C.P., Sakamoto, S., Pal, S. and Sen, G.C. (2004) Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat. Struct. Mol. Biol. 11, 1060-1067
41. Ni, M., MacFarlane, 4th, A.W., Toft, M., Lowell, C.A., Campbell, K.S. and Hamerman, J.A. (2012) B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proc. Natl. Acad. Sci. U.S.A. 109, 267-272
42. Troutman, T.D., Hu, W., Fulenchek, S., Yamazaki, T., Kurosaki, T., Bazan, J.F. and Pasare, C. (2012) Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc. Natl. Acad. Sci. U.S.A. 109, 273-278
43. Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 9, 361-368
44. Kagan, J.C. and Medzhitov, R. (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955
45. Pearce, L.R., Komander, D. and Alessi, D.R. (2010) The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22
46. Brown, J., Wang, H., Suttles, J., Graves, D.T. and Martin, M. (2011) Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. J. Biol. Chem. 286, 44295-44305
47. Chaurasia, B., Mauer, J., Koch, L., Goldau, J., Kock, A.S. and Bruning, J.C. (2010) Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-κB activation in macrophages. Mol. Cell. Biol. 30, 4354-4366
48. Arranz, A., Doxaki, C., Vergadi, E., Martinez de la Torre, Y., Vaporidi, K., Lagoudaki, E.D., Ieronymaki, E., Androulidaki, A., Venihaki, M., Margioris, A.N. et al. (2012) Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc. Natl. Acad. Sci. U.S.A. 109, 9517-9522
49. Ohtani, M., Nagai, S., Kondo, S., Mizuno, S., Nakamura, K., Tanabe, M., Takeuchi, T., Matsuda, S. and Koyasu, S. (2008) Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide- induced interleukin-12 production in dendritic cells. Blood 112, 635-643
50. Martin, M., Rehani, K., Jope, R.S. and Michalek, S.M. (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777-784
51. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. and Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
52. Hu, X., Paik, P.K., Chen, J., Yarilina, A., Kockeritz, L., Lu, T.T., Woodgett, J.R. and Ivashkiv, L.B. (2006) IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574
53. Hacker, H. and Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13
54. Kishore, N., Sommers, C., Mathialagan, S., Guzova, J., Yao, M., Hauser, S., Huynh, K., Bonar, S., Mielke, C., Albee, L. et al. (2003) A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1β- stimulated synovial fibroblasts. J. Biol. Chem. 278, 32861-32871
55. Clark, K., Peggie, M., Plater, L., Sorcek, R.J., Young, E.R., Madwed, J.B., Hough, J., McIver, E.G. and Cohen, P. (2011) Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434, 93-104
56. Senftleben, U., Cao, Y., Xiao, G., Greten, F.R., Krahn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.C. and Karin, M. (2001) Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495-1499
57. Li, Q., Lu, Q., Hwang, J.Y., Buscher, D., Lee, K.F., Izpisua-Belmonte, J.C. and Verma, I.M. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1322-1328
58. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N. and Akira, S. (1999) Limb and skin abnormalities in mice lacking IKKα. Science 284, 313-316
59. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316-320
60. Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. and Karin, M. (2005) IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143
61. Shembade, N., Pujari, R., Harhaj, N.S., Abbott, D.W. and Harhaj, E.W. (2011) The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1. Nat. Immunol. 12, 834-843
62. Shembade, N., Parvatiyar, K., Harhaj, N.S. and Harhaj, E.W. (2009) The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling. EMBO J. 28, 513-522
63. Shembade, N., Harhaj, N.S., Parvatiyar, K., Copeland, N.G., Jenkins, N.A., Matesic, L.E. and Harhaj, E.W. (2008) The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9, 254-262
64. Skaug, B., Chen, J., Du, F., He, J., Ma, A. and Chen, Z.J. (2011) Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 44, 559-571
65. Fong, C.H., Bebien, M., Didierlaurent, A., Nebauer, R., Hussell, T., Broide, D., Karin, M. and Lawrence, T. (2008) An antiinflammatory role for IKKβ through the inhibition of "classical" macrophage activation. J. Exp. Med. 205, 1269-1276
66. Sica, A. and Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122, 787-795
67. Clark, K., Plater, L., Peggie, M. and Cohen, P. (2009) Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IκB kinase ε: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284, 14136-14146
68. Clark, K., Takeuchi, O., Akira, S. and Cohen, P. (2011) The TRAF-associated protein TANK facilitates cross-talk within the IκB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 17093-17098
69. Jin, J., Xiao, Y.C., Chang, J.H., Yu, J.Y., Hu, H.B., Starr, R., Brittain, G.C., Chang, M., Cheng, X.H. and Sun, S.C. (2012) The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling. Nat. Immunol. 13, 1101-1109
70. Kishore, N., Huynh, Q.K., Mathialagan, S., Hall, T., Rouw, S., Creely, D., Lange, G., Caroll, J., Reitz, B., Donnelly, A. et al. (2002) IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. J. Biol. Chem. 277, 13840-13847
71. Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A. and Akira, S. (1999) IKK-i, a novel lipopolysaccharideinducible kinase that is related to IκB kinases. Int. Immunol. 11, 1357-1362
72. Soulat, D., Burckstummer, T., Westermayer, S., Goncalves, A., Bauch, A., Stefanovic, A., Hantschel, O., Bennett, K.L., Decker, T. and Superti-Furga, G. (2008) The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27, 2135-2146
73. Delhase, M., Hayakawa, M., Chen, Y. and Karin, M. (1999) Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science 284, 309-313
74. Reilly, S.M., Chiang, S.H., Decker, S.J., Chang, L., Uhm, M., Larsen, M.J., Rubin, J.R., Mowers, J., White, N.M., Hochberg, I. et al. (2013) An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice. Nat. Med. 19, 313-321
75. Marienfeld, R.B., Palkowitsch, L. and Ghosh, S. (2006) Dimerization of the IκB kinase-binding domain of NEMO is required for tumor necrosis factor α-induced NF-κB activity. Mol. Cell. Biol. 26, 9209-9219
76. Prajapati, S. and Gaynor, R.B. (2002) Regulation of IκB kinase (IKK) γ/NEMO function by IKKβ-mediated phosphorylation. J. Biol. Chem. 277, 24331-24339
77. Pomerantz, J.L. and Baltimore, D. (1999) NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18, 6694-6704
78. Morton, S., Hesson, L., Peggie, M. and Cohen, P. (2008) Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 582, 997-1002
79. Ryzhakov, G. and Randow, F. (2007) SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26, 3180-3190
80. Fujita, F., Taniguchi, Y., Kato, T., Narita, Y., Furuya, A., Ogawa, T., Sakurai, H., Joh, T., Itoh, M., Delhase, M. et al. (2003) Identification of NAP1, a regulatory subunit of IκB kinase-related kinases that potentiates NF-κB signaling. Mol. Cell. Biol. 23, 7780-7793
81. Goncalves, A., Burckstummer, T., Dixit, E., Scheicher, R., Górna, M.W., Karayel, E., Sugar, C., Stukalov, A., Berg, T., Kralovics, R. et al. (2011) Functional dissection of the TBK1 molecular network. PLoS ONE 6, e23971
82. Fukasaka, M., Ori, D., Kawagoe, T., Uematsu, S., Maruyama, K., Okazaki, T., Kozaki, T., Imamura, T., Tartey, S., Mino, T. et al. (2013) Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation. J. Immunol. 190, 5702-5711
83. Gleason, C.E., Ordureau, A., Gourlay, R., Arthur, J.S. and Cohen, P. (2011) Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J. Biol. Chem. 286, 35663-35674
84. Chariot, A., Leonardi, A., Muller, J., Bonif, M., Brown, K. and Siebenlist, U. (2002) Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKε and TBK1 kinases. J. Biol. Chem. 277, 37029-37036
85. Liu, J., Sudom, A., Min, X., Cao, Z., Gao, X., Ayres, M., Lee, F., Cao, P., Johnstone, S., Plotnikova, O. et al. (2012) Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation. J. Biol. Chem. 287, 27326-27334
86. Qing, G., Qu, Z. and Xiao, G. (2005) Stabilization of basally translated NF-κB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-κB2 p100. J. Biol. Chem. 280, 40578-40582
87. Liao, G., Zhang, M., Harhaj, E.W. and Sun, S.C. (2004) Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243-26250
88. Zarnegar, B.J., Wang, Y., Mahoney, D.J., Dempsey, P.W., Cheung, H.H., He, J., Shiba, T., Yang, X., Yeh, W.C., Mak, T.W. et al. (2008) Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9, 1371-1378
89. Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.H., Keats, J.J., Wang, H., Vignali, D.A., Bergsagel, P.L. and Karin, M. (2008) Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364-1370
90. Dzamko, N., Inesta-Vaquera, F., Zhang, J., Xie, C., Cai, H., Arthur, S., Tan, L., Choi, H., Gray, N., Cohen, P. et al. (2012) The IκB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling. PLoS ONE 7, e39132
91. Xie, X., Zhang, D., Zhao, B., Lu, M.K., You, M., Condorelli, G., Wang, C.Y. and Guan, K.L. (2011) IκB kinase ε and TANK-binding kinase 1 activate AKT by direct phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 108, 6474-6479
92. Ou, Y.H., Torres, M., Ram, R., Formstecher, E., Roland, C., Cheng, T., Brekken, R., Wurz, R., Tasker, A., Polverino, T. et al. (2011) TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation. Mol. Cell 41, 458-470
93. Mosser, D.M. and Edwards, J.P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969
94. Martinez, F.O., Helming, L. and Gordon, S. (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483
95. van der Pouw Kraan, T.C., Boeije, L.C., Smeenk, R.J., Wijdenes, J. and Aarden, L.A. (1995) Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779
96. Alvarez, Y., Municio, C., Alonso, S., Sanchez Crespo, M. and Fernandez, N. (2009) The induction of IL-10 by zymosan in dendritic cells depends on CREB activation by the coactivators CREB-binding protein and TORC2 and autocrine PGE2. J. Immunol. 183, 1471-1479
97. Altarejos, J.Y. and Montminy, M. (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141-151
98. Clark, K., MacKenzie, K.F., Petkevicius, K., Kristariyanto, Y., Zhang, J., Choi, H.G., Peggie, M., Plater, L., Pedrioli, P.G., McIver, E. et al. (2012) Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc. Natl. Acad. Sci. U.S.A. 109, 16986-16991
99. Mackenzie, K.F., Clark, K., Naqvi, S., McGuire, V.A., Noehren, G., Kristariyanto, Y., van den Bosch, M., Mudaliar, M., McCarthy, P.C., Pattison, M.J. et al. (2013) PGE2 induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway. J. Immunol. 190, 565-577